Operating Income (Loss) in USD of ROCKWELL MEDICAL, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ROCKWELL MEDICAL, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • ROCKWELL MEDICAL, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$1,584,000.000, a 182% decline year-over-year.
  • ROCKWELL MEDICAL, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$4,812,000.000, a 930% decline year-over-year.
  • ROCKWELL MEDICAL, INC. annual Operating Income (Loss) for 2024 was $608,000.000.
  • ROCKWELL MEDICAL, INC. annual Operating Income (Loss) for 2023 was -$6,670,000.000, a 60.3% increase from 2022.
  • ROCKWELL MEDICAL, INC. annual Operating Income (Loss) for 2022 was -$16,780,000.000, a 44.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

ROCKWELL MEDICAL, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$4,812,000 -$1,584,000 -$3,520,000 -1.8% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$1,292,000 -$1,349,000 -$1,864,000 -3.6% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $572,000 -$1,360,000 -$36,000 -2.7% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $608,000 -$519,000 +$28,000 +5.1% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $580,000 $1,936,000 +$3,673,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$3,093,000 $515,000 +$3,474,000 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$6,567,000 -$1,324,000 +$103,000 +7.2% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 -$6,670,000 -$547,000 +$1,417,000 +72.1% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$8,087,000 -$1,737,000 +$1,971,000 +53.2% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$10,058,000 -$2,959,000 +$1,523,000 +34% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$11,581,000 -$1,427,000 +$5,199,000 +78.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$16,780,000 -$1,964,000 +$6,395,000 +76.5% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$23,175,000 -$3,708,000 +$3,264,000 +46.8% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$26,439,000 -$4,482,000 +$3,341,000 +42.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$29,780,000 -$6,626,000 +$556,000 +7.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$30,336,000 -$8,359,000 -$287,000 -3.6% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$30,049,000 -$6,972,000 -$282,000 -4.2% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$29,767,000 -$7,823,000 -$2,220,000 -39.6% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$27,547,000 -$7,182,000 +$873,000 +10.8% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$28,420,000 -$8,072,000 -$669,555 -9% 01 Oct 2020 31 Dec 2020 10-K 08 Apr 2022
Q3 2020 -$27,750,445 -$6,690,000 +$1,252,000 +15.8% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$29,002,445 -$5,603,000 +$4,767,794 +46% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$33,770,239 -$8,055,000 +$754,761 +8.6% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$34,525,000 -$7,402,445 +$2,022,486 +21.5% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$36,547,486 -$7,942,000 -$2,943,477 -58.9% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$33,604,009 -$10,370,794 +$1,926,109 +15.7% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$35,530,118 -$8,809,761 -$3,090,957 -54% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$32,439,161 -$9,424,931 -$203,735 -2.2% 01 Oct 2018 31 Dec 2018 10-K 17 Mar 2020
Q3 2018 -$32,235,426 -$4,998,523 +$26,720 +0.53% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$32,262,146 -$12,296,903 -$5,578,518 -83% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$26,683,628 -$5,718,804 -$760,710 -15.3% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 -$25,922,918 -$9,221,196 -$3,958,987 -75.2% 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2018
Q3 2017 -$21,963,931 -$5,025,243 -$273,134 -5.7% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 -$21,690,797 -$6,718,385 -$1,130,219 -20.2% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$20,560,578 -$4,958,094 -$351,849 -7.6% 01 Jan 2017 31 Mar 2017 10-Q/A 14 Aug 2018
Q4 2016 -$20,208,729 -$5,262,209 +$800,985 +13.2% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 -$21,009,714 -$4,752,109 -$2,180,884 -84.8% 01 Jul 2016 30 Sep 2016 10-K 15 Mar 2018
Q2 2016 -$18,828,830 -$5,588,166 -$2,933,268 -1.1% 01 Apr 2016 30 Jun 2016 10-K 15 Mar 2018
Q1 2016 -$15,895,562 -$4,606,245 -$793,236 -20.8% 01 Jan 2016 31 Mar 2016 10-K 15 Mar 2018
Q4 2015 -$15,102,326 -$6,063,194 -$1,042,383 -20.8% 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 -$14,059,943 -$2,571,225 +$559,617 +17.9% 01 Jul 2015 30 Sep 2015 10-K 15 Mar 2017
Q2 2015 -$14,619,560 -$2,654,898 -$272,890 -11.5% 01 Apr 2015 30 Jun 2015 10-K 15 Mar 2017
Q1 2015 -$14,346,670 -$3,813,009 +$3,212,429 +45.7% 01 Jan 2015 31 Mar 2015 10-K 15 Mar 2017
Q4 2014 -$17,559,099 -$5,020,811 +$2,508,199 +33.3% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$20,067,298 -$3,130,842 +$9,233,463 +74.7% 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 -$29,300,761 -$2,382,008 +$9,393,622 +79.8% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$38,694,383 -$7,025,438 +$8,364,883 +54.4% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 -$47,059,266 -$7,529,010 +$6,155,407 +45% 01 Oct 2013 31 Dec 2013 10-K 03 Mar 2015
Q3 2013 -$53,214,673 -$12,364,305 +$5,553,629 +31% 01 Jul 2013 30 Sep 2013 10-K 03 Mar 2015
Q2 2013 -$58,768,302 -$11,775,630 +$206,346 +1.7% 01 Apr 2013 30 Jun 2013 10-K 03 Mar 2015
Q1 2013 -$58,974,648 -$15,390,321 -$4,712,566 -44.1% 01 Jan 2013 31 Mar 2013 10-K 03 Mar 2015
Q4 2012 -$54,262,082 -$13,684,417 -$4,728,857 -52.8% 01 Oct 2012 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 -$49,533,225 -$17,917,934 -$12,801,651 -2.5% 01 Jul 2012 30 Sep 2012 10-K 07 Mar 2014
Q2 2012 -$36,731,574 -$11,981,976 -$7,366,666 -1.6% 01 Apr 2012 30 Jun 2012 10-K 07 Mar 2014
Q1 2012 -$29,364,908 -$10,677,755 -$7,680,151 -2.6% 01 Jan 2012 31 Mar 2012 10-K 07 Mar 2014
Q4 2011 -$21,684,757 -$8,955,560 01 Oct 2011 31 Dec 2011 10-K 18 Mar 2013
Q3 2011 -$5,116,283 -$4,357,131 -5.7% 01 Jul 2011 30 Sep 2011 10-K 18 Mar 2013
Q2 2011 -$4,615,310 -$4,724,366 -43.3% 01 Apr 2011 30 Jun 2011 10-K 18 Mar 2013
Q1 2011 -$2,997,604 01 Jan 2011 31 Mar 2011 10-K 18 Mar 2013
Q3 2010 -$759,152 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q2 2010 $109,056 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011

ROCKWELL MEDICAL, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $608,000 +$7,278,000 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$6,670,000 +$10,110,000 +60.2% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$16,780,000 +$13,556,000 +44.7% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$30,336,000 -$1,916,000 -6.7% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$28,420,000 +$6,105,000 +17.7% 01 Jan 2020 31 Dec 2020 10-K 08 Apr 2022
2019 -$34,525,000 -$2,085,839 -6.4% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$32,439,161 -$6,516,243 -25.1% 01 Jan 2018 31 Dec 2018 10-K 17 Mar 2020
2017 -$25,922,918 -$5,714,189 -28.3% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019
2016 -$20,208,729 -$5,106,403 -33.8% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018
2015 -$15,102,326 +$2,456,775 +14% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018
2014 -$17,559,101 +$29,500,165 +62.7% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017
2013 -$47,059,266 +$7,202,816 +13.3% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$54,262,082 -$32,577,325 -1.5% 01 Jan 2012 31 Dec 2012 10-K 03 Mar 2015
2011 -$21,684,757 -$18,815,841 -6.6% 01 Jan 2011 31 Dec 2011 10-K 07 Mar 2014
2010 -$2,868,916 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.